within Pharmacolibrary.Drugs.B_BloodAndBloodFormingOrgans.B06A_OtherHematologicalAgents.B06AC06_Berotralstat;
model Berotralstat 
   extends Pharmacolibrary.Drugs.ATC.B.B06AC06;

  annotation(Documentation(
    info ="<html><body><p>Berotralstat is an oral, once-daily, small-molecule inhibitor of plasma kallikrein, used for the prophylaxis of hereditary angioedema (HAE) attacks. It is approved for use in several countries including the US and EU.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetics in healthy adult subjects and patients with hereditary angioedema following daily oral administration.</p><h4>References</h4><ol></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>",
    experiment(StartTime = 0, StopTime = 86400, Tolerance = 1e-09, Interval = 1)
  ));  
end Berotralstat;
